Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/08/2859242/10391/en/TRACON-Pharmaceuticals-Announces-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2024/04/03/2856880/10391/en/TRACON-Pharmaceuticals-Provides-Update-on-Ongoing-ENVASARC-Phase-2-Pivotal-Trial-Following-Independent-Data-Monitoring-Committee-Recommendation-to-Continue-the-Trial-as-Planned.html
https://www.globenewswire.com//news-release/2024/03/05/2840884/10391/en/TRACON-Pharmaceuticals-Reports-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/02/28/2837397/10391/en/TRACON-to-Report-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provide-Corporate-Update-on-March-5-2024.html
https://www.globenewswire.com//news-release/2023/12/20/2799215/10391/en/TRACON-Pharmaceuticals-Provides-Positive-Update-on-Ongoing-ENVASARC-Pivotal-Phase-2-Trial.html
https://www.globenewswire.com/news-release/2023/11/20/2783188/10391/en/TRACON-Pharmaceuticals-Announces-License-of-Product-Development-Platform-for-3-0-Million-Upfront-Payment.html
https://www.globenewswire.com//news-release/2023/11/09/2777785/10391/en/TRACON-Pharmaceuticals-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2023/10/31/2770612/10391/en/TRACON-to-Report-Third-Quarter-2023-Financial-Results-and-Provide-Corporate-Update-on-November-9-2023.html
https://www.globenewswire.com//news-release/2023/09/18/2744705/10391/en/TRACON-Pharmaceuticals-Announces-ENVASARC-Phase-2-Pivotal-Trial-Exceeded-Futility-Threshold-at-Final-Interim-Analysis-and-Will-Continue-as-Planned.html
https://www.globenewswire.com//news-release/2023/09/05/2737863/10391/en/TRACON-Pharmaceuticals-Announces-Participation-at-Upcoming-Investor-Conferences.html